Table 2.
Clinical outcomes | Overall (N = 562) | Sex | Age group (years) | District | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male (n = 280) | Female (n = 282) | χ 2 | P | 8–12 (n = 122) | 13–16 (n = 440) | χ 2 | P | Dolakha (n = 444) | Ramechhap (n = 118) | χ 2 | P | ||
N (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||||||
Symptoms in past two weeks | |||||||||||||
Fever | 174 (31.0) | 84 (30.0) | 90 (31.9) | 0.24 | 0.62 | 37 (30.3) | 137 (31.1) | 0.02 | 0.86 | 146 (32.9) | 28 (23.7) | 3.07 | 0.05 |
Diarrhoea | 126 (22.4) | 66 (23.6) | 60 (21.3) | 0.43 | 0.51 | 38 (31.1) | 88 (20.0) | 6.82 | 0.01 | 104 (23.4) | 22 (18.6) | 1.02 | 0.27 |
Blood in stool | 8 (1.4) | 5 (1.8) | 3 (1.1) | 0.52 | 0.47 | 2 (1.6) | 6 (1.4) | 0.05 | 0.82 | 4 (0.9) | 4 (3.4) | 4.01 | 0.04 |
Mucus in stool | 16 (2.8) | 5 (1.8) | 11 (3.9) | 2.27 | 0.13 | 5 (4.1) | 11 (2.5) | 0.88 | 0.35 | 15 (3.4) | 1 (0.8) | 2.02 | 0.14 |
Physical examination | |||||||||||||
Hepatomegaly | 1 (0.2) | 1 (0.4) | 0 (0) | 1.00 | 0.32 | 1 (0.8) | 0 (0) | 3.61 | 0.05 | 1 (0.2) | 0 (0) | 0.03 | 0.60 |
Pale conjunctiva | 55 (9.8) | 24 (8.6) | 31 (11.0) | 0.93 | 0.33 | 16 (13.1) | 39 (8.9) | 1.96 | 0.16 | 43 (9.7) | 12 (10.2) | 0.02 | 0.88 |
P-values were obtained by χ2 test; values in boldface indicate statistically significant differences